have a great immunogenicity for humans. We cloned and produced a recombinant protein
(recTgPDI) used to test its effect during infection to different human cell lines (epithelial and
retinal). We also determine if there were differences in gen expression during in vitro
infection. Expression of the gen was lower after entry into the host cells. PDI's inhibitors
bacitracin and nitroblue tetrazolium reduced the percent of infected cells and small amounts …